View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Deals Analysis
April 19, 2022

Medical Devices industry cross border deals total $1.3bn globally in March 2022

By Nikitha Ladda

Total medical devices industry cross border deals worth $1.3bn were announced globally for March 2022, with the $240m acquisition of Ivenix being the sector’s biggest investment, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked a decrease of 43.4% over the previous month of $2.35bn and a drop of 81.1% when compared with the last 12-month average of $7.03bn.

In terms of number of cross border deals, the sector saw a rise of 15.00% with 69 deals in March 2022 when compared to the last 12-month average of 60 deals.

In value terms, North America led the activity with cross border deals worth $844m in March 2022.

medical devices industry cross border deals in March 2022: Top deals

The top five cross border deals accounted for 50.3% of the overall value during March 2022.

The combined value of the top five cross border deals stood at $670m, against the overall value of $1.3bn recorded for the month.

The top five medical devices industry cross border deals of March 2022 tracked by GlobalData were:

1) Fresenius Kabi $240m acquisition deal with Ivenix

2) The $125m private equity of Saluda Medical by Fidelity Management & Research,Redmile Group and T Rowe Price Associates

3) Adams Street Partners,Baillie Gifford,Civilization Ventures,Fifty Years Fund,Hummingbird Ventures,Libertus Capital,NeoTribe Ventures,Norwest Venture Partners,Pacific 8 Ventures and Time BioVentures $125m venture financing deal with BillionToOne

4) The $100m venture financing of Visby Medical by Artiman Ventures,Blue Water Life Science Advisors,Cedars-Sinai Medical Center,Healthcare of Ontario Pension Plan,John Doerr,ND Capital,Nissim Capital,Ping An Voyager Partners and Pitango Venture Capital

5) Ally Bridge Group,Ascension Health Ventures,Catalio Capital Management,Hillenbrand Capital,Johnson & Johnson Innovation – JJDC,KCK Group,Pfizer Venture Investments,PSP INVESTMENTS,Sixty Degree Capital,T Rowe Price Associates,The Rise Fund and Venrock Healthcare Capital Partners $80m venture financing deal with RefleXion Medical

Related Companies

Verdict deals analysis methodology

This analysis considers only announced and completed cross border deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.

Topics in this article: ,
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU